FDA Quality of Life Subcommittee
Executive Summary
The first meeting of the new subcommittee of the Oncologic Drugs Advisory Committee will take place Feb. 10 (1"The Pink Sheet" Dec. 20, 1999, In Brief). The panel will discuss the definition of patient centered outcomes, clinical significance in interpretation of study results and approaches to statistical analysis of data. The meeting will take place at 8:00 a.m. at the Ramada Inn in Bethesda, Md